CureVac N.V. (CVAC) P/E Ratio History
Premium ValuationTrading at 6.5x vs 5Y avg 5.1x · 100th percentile · Premium to historical baseline · Data 2024–2025
Loading P/E history...
P/E Ratio Analysis
As of October 3, 2026, CureVac N.V. (CVAC) trades at a price-to-earnings ratio of 6.5x, with a stock price of $4.66 and trailing twelve-month earnings per share of $0.86.
The current P/E is 28% above its 5-year average of 5.1x. Over the past five years, CVAC's P/E has ranged from a low of 3.4x to a high of 6.2x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.2x, CVAC trades at a 72% discount to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 190.0x.
Relative to the broader market, CVAC trades at a notable discount to the S&P 500 median P/E of 24.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CVAC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CVAC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CVAC P/E vs Peers
Vaccines and Infectious Disease peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $29B | 94.3 | - | +207%Best | |
| $158B | 20.4Lowest | - | -4% | |
| $616B | 23.2 | 1.56Best | +91% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CVAC Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Jun 30 2025 | $5.43 | $0.87 | 6.2x | +24% |
| FY2025 Q1 | Mar 31 2025 | $2.77 | $0.81 | 3.4x | -32% |
| FY2024 Q4 | - | $3.41 | $0.73 | 4.7x | -8% |
| FY2024 Q3 | Sep 30 2024 | $2.94 | $0.50 | 5.9x | +16% |
Average P/E for displayed period: 5.1x
CVAC Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CVAC — Frequently Asked Questions
Quick answers to the most common questions about buying CVAC stock.
What is CVAC's P/E ratio?
CureVac N.V. (CVAC) trailing twelve-month P/E ratio is 6.5x, based on TTM diluted EPS of $0.86. The 5-year average P/E is 5.1x and the historical range spans 3.4x to 6.2x.
Is CVAC stock overvalued or undervalued?
CVAC trades at 6.5x P/E, above its 5-year average of 5.1x. The 100th percentile ranking within the 3.4x–6.2x historical range indicates a premium to historical valuation.
Is CVAC stock expensive?
Yes, CVAC is expensive relative to its own history. The current P/E of 6.5x is above the 5-year average of 5.1x. The stock sits at the 100th percentile of its 5-year valuation range.
What is CVAC's historical P/E range?
Over the past 5 years, CVAC's P/E ratio has ranged from 3.4x to 6.2x, with a median of 5.9x and an average of 5.1x. The current P/E of 6.5x places the stock at the 100th percentile of this range. Full historical data spans 2024–2025.
How does CVAC's P/E compare to the S&P 500?
CVAC trades at 6.5x P/E versus the S&P 500 median of 24.5x. The 73% discount to the market suggests lower growth expectations or perceived higher risk.
How does CVAC's valuation compare to Healthcare peers?
CureVac N.V. P/E of 6.5x compares to the Healthcare sector median of 23.2x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CVAC's PEG ratio?
CVAC PEG ratio is N/A, based on a P/E of 6.5x and EPS growth of 161.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CVAC's earnings yield?
CVAC earnings yield is 15.45%, the inverse of its 6.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.